The present invention relates to novel polymorphic forms of sitagliptin hydrochloride, processes for its preparation and pharmaceutical compositions comprising the same.La présente invention concerne de nouvelles formes polymorphes de chlorhydrate de sitagliptine, des procédés de préparation et des compositions pharmaceutiques les comprenant.